Prospective observational multicenter study of patients with AH and CKD markers in Kazakhstan (PROGRESS-CKD) - D1843R00359

Inclusion Criteria

• Age ≥18 years at the time of inclusion;
• • Patient signed and dated written informed consent form (ICF) in accordance with ICH GCP and
• local legislation prior to inclusion in the study for the prospective observational cohort;
• • Established diagnosis of hypertension, diagnosed in accordance with current clinical guidelines
• for hypertension, i.e. in adults, i.e. systolic blood pressure (SBP) ≥140 mmHg and/or diastolic
• blood pressure (DBP) ≥90 mmHg. when measured at two different visits
• • Laboratory markers of CKD (eGFR <60 mL/min/1.73 m2 and/or albuminuria/proteinuria*)
• measured during the period ≥3 and ≤12 months prior to inclusion in the study without a recorded
• diagnosis of CKD in the primary medical record prior to inclusion;
• * any of the following: urine albumin/creatinine ratio (UACR) ≥30 mg/g (3 mg/mmol), urine total
• protein(protein)/creatinine ratio ≥150 mg/g (15 mg/mmol), albuminuria ≥30 mg/d or proteinuria ≥0.15
• mg/d.
• • Absence of documented diagnosis of CKD in the patient's medical records prior to inclusion in the
• study
• -